Potassium iodide and Cholestyramine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Potassium iodide (potassium iodide) and Cholestyramine (cholestyramine). Common drug interactions include drug ineffective among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Potassium iodide and Cholestyramine. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Potassium iodide?

Potassium iodide has active ingredients of potassium iodide. It is often used in thyroid diseases. eHealthMe is studying from 1,919 Potassium iodide users. Check the latest studies of Potassium iodide.

What is Cholestyramine?

Cholestyramine has active ingredients of cholestyramine. It is often used in diarrhea. eHealthMe is studying from 9,893 Cholestyramine users. Check the latest studies of Cholestyramine.

On Jul, 05, 2026

30 people who take Potassium iodide and Cholestyramine together, and have interactions are studied.

Potassium iodide and Cholestyramine drug interactions.

What are the common drug interactions of Potassium Iodide and Cholestyramine, by gender? *:

female:

Drug ineffective
Acute hepatic failure
Maternal exposure during pregnancy (use of substance during pregnancy)
Hepatitis cholestatic (flow of bile from the liver is slowed or blocked)
Hepatotoxicity (chemical-driven liver damage)
Nephropathy toxic (damage to kidney due to toxins)
Respiratory distress (difficulty in breathing)
Sepsis (a severe blood infection that can lead to organ failure and death)
Thyroid mass
Thyrotoxic crisis (a life threatening condition due to excess secretion of thyroid hormone)

male:

Drug ineffective
Hyperthyroidism (over activity of the thyroid gland)
Leukopenia (less number of white blood cells in blood)
Neutropenia (an abnormally low number of neutrophils)
Thrombocytopenia (decrease of platelets in blood)
Thyrotoxic crisis (a life threatening condition due to excess secretion of thyroid hormone)
Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
Acute hepatic failure
Hepatotoxicity (chemical-driven liver damage)
Cardiac arrest

What are the common drug interactions of Potassium Iodide and Cholestyramine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Haemodynamic instability (disturbances in the blood movement in our body)

30-39:

Drug ineffective
Neutropenia (an abnormally low number of neutrophils)
Sepsis (a severe blood infection that can lead to organ failure and death)
Abdominal pain
Abortion spontaneous (naturally occurring miscarriage)
Acute respiratory distress syndrome
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Ecthyma (an ulcerative pyoderma of the skin, caused by group a beta haemolytic streptococci)
Haemothorax (collection of blood in the pleural space (the space between the lungs and the walls of the chest))
Immunodeficiency

40-49:

Acute hepatic failure
Drug ineffective
Hepatitis cholestatic (flow of bile from the liver is slowed or blocked)
Hepatotoxicity (chemical-driven liver damage)
Aspartate aminotransferase increased
Ejection fraction (the percentage of blood that is pumped out of a filled ventricle as a result of a heartbeat)
Ischaemic hepatitis (decreased blood supply to the liver resulting in injury to liver cells)
Myocarditis (inflammation of heart muscle myocardium)

50-59:

Thyroid mass
Thyrotoxic crisis (a life threatening condition due to excess secretion of thyroid hormone)
Disseminated intravascular coagulation (systemic activation of blood coagulation)
Haemorrhage (bleeding)
Thrombocytopenia (decrease of platelets in blood)
Drug ineffective
Hyperthyroidism (over activity of the thyroid gland)
Respiratory distress (difficulty in breathing)

60+:

Hyperthyroidism (over activity of the thyroid gland)
Nephropathy toxic (damage to kidney due to toxins)
Cardiac arrest
Cardiogenic shock (inadequate circulation of blood)
Drug ineffective
Thyrotoxic crisis (a life threatening condition due to excess secretion of thyroid hormone)
Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)

What are the existing conditions these people have? *

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 13 people, 43.33%
Thyrotoxic Crisis (a life threatening condition due to excess secretion of thyroid hormone): 11 people, 36.67%
Hyperthyroidism (over activity of the thyroid gland): 7 people, 23.33%
Tachyarrhythmia (disturbance of the heart rhythm in which the heart rate is abnormally increased): 2 people, 6.67%
Basedow's Disease (autoimmune disease where the thyroid is overactive, producing an excessive amount of thyroid hormones): 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Potassium iodide and Cholestyramine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously